Archive - April 2021
GSK wins approval for anti-PD-1 antibody Jemperli in endometrial cancer
EU may seek legal action against AstraZeneca following vaccine supply cuts
J&J halts manufacturing of COVID-19 at US plant after FDA warning
PARP inhibitors could exploit weaknesses in a range of cancers
FDA approves GSK’s Jemperli for dMMR endometrial cancer
BMS to invest in new cell therapy manufacturing site in Europe
MHRA authorises Amarin’s heart drug Vazkepa
Healthware Group acquires London-headquartered consultancy SWM